TumorAgDB1.0 offers a user-friendly platform. Users can efficiently search for neoantigen data using parameters like amino acid sequence and peptide length. The platform also offers detailed informati
The ATLAS bioassay was developed to empirically identify neoantigens by expressing each unique patient-specific tumor mutation individually in E. coli, pulsing autologous dendritic cells in an ordered
